Clinical Trial Update: Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of romidepsin for patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Glioma
• Lymphoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioma, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Status: COMPLETED